.
.
executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday
.
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.
.